Sponsor Pipeline

Neurocentrx Pharma Pty Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07644767 Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar Depression Treatment Resistant Bipolar Depression Not Yet Recruiting
Disease Areas
Depression (1) Bipolar Disorder (1)
Get alerts when Neurocentrx Pharma Pty Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free